Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
12674
Description
Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
Keywords
Versions (5)
- 3/4/15 3/4/15 -
- 3/9/15 3/9/15 -
- 4/23/15 4/23/15 -
- 12/9/15 12/9/15 -
- 2/11/16 2/11/16 -
Uploaded on
December 9, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Concomitant Medication AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Concomitant Medication AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Similar models
Concomitant Medication AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
CL Item
Diagnostic (0)
C0086143 (UMLS CUI-1)
CL Item
Induction I (1)
C3179010 (UMLS CUI-1)
CL Item
Induction II (optional) (2)
C3179010 (UMLS CUI-1)
CL Item
Consolid. I (3)
C3179017 (UMLS CUI-1)
CL Item
Consolid. II (4)
C3179017 (UMLS CUI-1)
CL Item
Consolid. III (5)
C3179017 (UMLS CUI-1)
CL Item
Consolid. IV (6)
C3179017 (UMLS CUI-1)
CL Item
Maintenance (7)
C0481504 (UMLS CUI-1)
Item
If Maintenance: Month
integer
C0481504 (UMLS CUI [1,1])
C0439231 (UMLS CUI [1,2])
C0439231 (UMLS CUI [1,2])
CL Item
after 1 Month (1)
C0439231 (UMLS CUI-1)
C0205447 (UMLS CUI-2)
C0205447 (UMLS CUI-2)
CL Item
after 2 Month (2)
C0439231 (UMLS CUI-1)
C0205448 (UMLS CUI-2)
C0205448 (UMLS CUI-2)
CL Item
after 3 Month (3)
C0439231 (UMLS CUI-1)
C0205449 (UMLS CUI-2)
C0205449 (UMLS CUI-2)
CL Item
after 4 Month (4)
C0439231 (UMLS CUI-1)
C0205450 (UMLS CUI-2)
C0205450 (UMLS CUI-2)
CL Item
after 5 Month (5)
C0439231 (UMLS CUI-1)
C0205451 (UMLS CUI-2)
C0205451 (UMLS CUI-2)
CL Item
after 6 Month (6)
C0439231 (UMLS CUI-1)
C0205452 (UMLS CUI-2)
C0205452 (UMLS CUI-2)
CL Item
after 7 Month (7)
C0439231 (UMLS CUI-1)
C0205453 (UMLS CUI-2)
C0205453 (UMLS CUI-2)
CL Item
after 8 Month (8)
C0439231 (UMLS CUI-1)
C0205454 (UMLS CUI-2)
C0205454 (UMLS CUI-2)
CL Item
after 9 Month (9)
C0439231 (UMLS CUI-1)
C0205455 (UMLS CUI-2)
C0205455 (UMLS CUI-2)
CL Item
after 10 Month (10)
C0439231 (UMLS CUI-1)
C0205456 (UMLS CUI-2)
C0205456 (UMLS CUI-2)
CL Item
after 11 Month (11)
C0439231 (UMLS CUI-1)
C0205457 (UMLS CUI-2)
C0205457 (UMLS CUI-2)
CL Item
after 12 Month (12)
C0439231 (UMLS CUI-1)
C0205458 (UMLS CUI-2)
C0205458 (UMLS CUI-2)
Pharmalogical Substance
Item
Pharmalogical Substance
text
C0013227 (UMLS CUI [1])
Dose
Item
Dose
integer
C3174092 (UMLS CUI [1])
Unit
Item
Unit
text
C0869039 (UMLS CUI-1)
CL Item
oral (1)
C0442027 (UMLS CUI-1)
CL Item
intravenous (2)
C0348016 (UMLS CUI-1)
CL Item
intramuscular (3)
C0442117 (UMLS CUI-1)
CL Item
subcutaneous (4)
C0443315 (UMLS CUI-1)
CL Item
sublingual (5)
C0001565 (UMLS CUI-1)
CL Item
rectal (6)
C0205052 (UMLS CUI-1)
CL Item
Inhalation (7)
C0205535 (UMLS CUI-1)
CL Item
topical (8)
C0332237 (UMLS CUI-1)
CL Item
other (9)
C0205394 (UMLS CUI-1)
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Medical indication
Item
Medical indication
text
C2315323 (UMLS CUI-1)
Start Date of Medication
Item
Start Date of Medication
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
Stop Date
Item
Stop Date Medication
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C2826892 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)
No comments